Saturday, February 11, 2012

Ahead of the Bell: Cephalon falls on Nuvigil delay

Ahead of the Bell: Cephalon falls on Nuvigil delay
Cephalon Inc. shares dipped in premarket trading Tuesday after regulators held up marketing approval for its drug Nuvigil as a treatment for jet lag.

Read more on AP via Yahoo! Finance

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay

Powered by Yahoo! Answers